This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
SUPS 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
How good is post-biopsy multiparametric magnetic resonance imaging in detecting and characterising the index lesion of localised prostate cancer? - Abstract
June 3, 2014
Impact of different setup approaches in image-guided radiotherapy as primary treatment for prostate cancer: A study of 2940 setup deviations in 980 MVCTs - Abstract
June 3, 2014
Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer - Abstract
June 3, 2014
Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis - Abstract
June 3, 2014
Burden of illness in prostate cancer patients with a low-to-moderate risk of progression: A one-year, pan-European observational study - Abstract
June 3, 2014
Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy - Abstract
June 3, 2014
Can we deliver randomized trials of focal therapy in prostate cancer? - Abstract
June 3, 2014
Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial - Abstract
June 2, 2014
High prevalence of screen-detected prostate cancer in West Africans: Implications for racial disparity of prostate cancer - Abstract
June 2, 2014
Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level - Abstract
June 2, 2014
Prostate cancer prognostic factors among Asian patients born in the US compared to those born abroad - Abstract
June 2, 2014
Assessing quality of life in patients with prostate cancer: A systematic and standardized comparison of available instruments - Abstract
June 2, 2014
Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term analysis of gastrointestinal and genitourinary toxicity - Abstract
June 2, 2014
The technique, resources and costs of stereotactic body radiotherapy of prostate cancer: A comparison of dose regimens and delivery systems - Abstract
June 2, 2014
Challenges in the sequencing of therapies for the management of metastatic castration-resistant prostate cancer - Abstract
June 2, 2014
Quality of life and sexual health in the aging of PCa survivors - Abstract
May 31, 2014
Image guided hypofractionated radiotherapy by Helical Tomotherapy for prostate carcinoma: Toxicity and impact on nadir PSA - Abstract
May 31, 2014
Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer - Abstract
May 31, 2014
Prostate-rectum spacers: Optimization of prostate cancer irradiation - Abstract
May 31, 2014
A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy - Abstract
May 31, 2014
Page 1004 of 1416
Start
Prev
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free